Eli Lilly and Company
Utility Patent Applications
Last updated:
List of all Eli Lilly and Company patents 234 in total
| Status | Patent |
|---|---|
Application | Utility: KRAS G12C INHIBITORS Filling date: 18 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: COMBINATION THERAPY WITH NOTCH AND PI3K/MTOR INHIBITORS FOR USE IN TREATING CANCER Filling date: 18 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: RAPID-ACTING INSULIN COMPOSITIONS Filling date: 18 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: ANTI-PACAP ANTIBODY Filling date: 18 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: RAMUCIRUMAB FOR THE TREATMENT OF CANCERS IN PEDIATRIC PATIENTS Filling date: 18 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: TREATMENT OF CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE Filling date: 18 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: ANGPTL 3/8 COMPLEXES AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: STATUS SENSING SYSTEM FOR INJECTION DEVICE Filling date: 18 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM Filling date: 18 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: [1,2,4]TRIAZOLO DERIVATIVES AS PDE1 INHIBITORS FOR THE TREATMENT OF DIABETES Filling date: 18 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS Filling date: 18 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Combination Therapy Filling date: 18 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: VARIANTS OF HUMAN BMP7 PROTEIN Filling date: 18 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS Filling date: 18 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: DRIVE ASSEMBLY FOR MOVING PISTON WITHIN CONTAINER Filling date: 18 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: DOSE DETECTION FOR A MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: STATUS SENSING SYSTEMS WITHIN AN INJECTION DEVICE ASSEMBLY Filling date: 18 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: 2,3-DIHYDROFURO[2,3-B]PYRIDINE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: IMIDAZOLIDINE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: IgG Bispecific Antibodies and Processes for Preparation Filling date: 18 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-1 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: Gripping Attachment for a Bottle Filling date: 18 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: SYSTEM FOR CONTROLLING GAS GENERATION WITHIN A DRUG DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: (E)-1-(4-(DIMETHYLAMINO)BUT-2-ENOYL)PYRROLIDIN-3-YL 4-((3-ISOPROPYL-5-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-7-YL)AMINO)PIPERIDINE-1-- CARBOXYLATE FOR INHIBITING CDK7 Filling date: 18 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: GIPR-AGONIST COMPOUNDS Filling date: 18 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: METHODS OF TREATING ULCERATIVE COLITIS Filling date: 18 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: CD73 INHIBITORS Filling date: 18 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: GLUCAGON-LIKE PEPTIDE1 RECEPTOR AGONISTS Filling date: 18 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: NASAL DRUG DELIVERY DEVICES Filling date: 18 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH A SENSED ELEMENT Filling date: 18 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-8-ONE DERIVATIVES Filling date: 18 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS Filling date: 18 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: DISUBSTITUTED PYRAZOLE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: FUSION PROTEINS Filling date: 18 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL Filling date: 18 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: MEDICATION DELIVERY SYSTEMS AND METHODS Filling date: 18 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: ANTI-CD137 ANTIBODIES Filling date: 18 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH SYRINGE SENSING SYSTEM Filling date: 18 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: 6-Fluoro-2-Methylbenzo[d]thiazol-5-yl Compounds Filling date: 18 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: COMPOUNDS AND METHODS TARGETING INTERLEUKIN-19 Filling date: 18 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: NEUREGULIN-4 COMPOUNDS AND METHODS OF USE Filling date: 18 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: PARATHYROID HORMONE-ANTI-RANKL ANTIBODY FUSION COMPOUNDS Filling date: 18 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: SELECTIVE ESTROGEN RECEPTOR DEGRADERS Filling date: 18 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: CLOSED LOOP CONTROL OF PHYSIOLOGICAL GLUCOSE Filling date: 18 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: Incretin Analogs and Uses Thereof Filling date: 18 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE Filling date: 18 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: ERGONOMIC CONNECTOR HUB FOR AN INFUSION SET Filling date: 18 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: MEDICATION DELIVERY SYSTEMS AND METHODS Filling date: 18 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: COMBINATION OF ERK1/2 INHIBITOR COMPOUND WITH GEMCITABINE OR WITH GEMCITABINE AND NAB-PACLITAXEL FOR USE IN TREATMENT OF PANCREATIC CANCER Filling date: 18 Sep 2025 Issue date: 1 Oct 2020 |
Showing 100 to 150 of 234 patents.